Medicines Earnings: What Investors Should Watch

Medicines (NASDAQ:MDCO) will report earnings before markets open on Wednesday, July 24th. The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

Here is your Cheat Sheet to Medicines Earnings:

Earnings Expectations: Analysts expect earnings of $0.34 per share on revenues of $168.73 million. Currently, the company’s P/E ratio stands at 51.94.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.39 to a profit $0.4. For the current year, the average estimate is a profit of $0.98, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Medicines has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 348 404 438 485 559
Diluted EPS ($) -0.16 -1.46 1.97 2.35 0.93

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 135.70 136.79 159.49 155.75
Diluted EPS ($) 0.25 0.17 0.38 -0.21

Past Performance:
Medicines has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]